azathioprine has been researched along with Delayed Effects, Prenatal Exposure in 14 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Belizna, C | 1 |
Meroni, PL | 1 |
Shoenfeld, Y | 1 |
Devreese, K | 1 |
Alijotas-Reig, J | 1 |
Esteve-Valverde, E | 1 |
Chighizola, C | 1 |
Pregnolato, F | 1 |
Cohen, H | 1 |
Fassot, C | 1 |
Mattera, PM | 1 |
Peretti, P | 1 |
Levy, A | 1 |
Bernard, L | 1 |
Saiet, M | 1 |
Lagarce, L | 1 |
Briet, M | 1 |
Rivière, M | 1 |
Pellier, I | 1 |
Gascoin, G | 1 |
Rakotonjanahary, J | 1 |
Borghi, MO | 1 |
Stojanovich, L | 1 |
Djokovic, A | 1 |
Stanisavljevic, N | 1 |
Bromley, R | 1 |
Elefant-Amoura, E | 1 |
Bahi Buisson, N | 1 |
Pindi Sala, T | 1 |
Kelchtermans, H | 1 |
Makatsariya, A | 1 |
Bidsatze, V | 1 |
Khizroeva, J | 1 |
Latino, JO | 1 |
Udry, S | 1 |
Henrion, D | 1 |
Loufrani, L | 1 |
Guihot, AL | 1 |
Muchardt, C | 1 |
Hasan, M | 1 |
Ungeheuer, MN | 1 |
Voswinkel, J | 1 |
Damian, L | 1 |
Pabinger, I | 1 |
Gebhart, J | 1 |
Lopez Pedrera, R | 1 |
Cohen Tervaert, JW | 1 |
Tincani, A | 2 |
Andreoli, L | 1 |
Mahadevan, U | 1 |
Long, MD | 1 |
Kane, SV | 1 |
Roy, A | 1 |
Dubinsky, MC | 1 |
Sands, BE | 1 |
Cohen, RD | 1 |
Chambers, CD | 1 |
Sandborn, WJ | 1 |
Thomas, C | 1 |
Monteil-Ganiere, C | 1 |
Mirallié, S | 1 |
Hémont, C | 1 |
Dert, C | 1 |
Léger, A | 1 |
Joyau, C | 1 |
Caldari, D | 1 |
Audrain, M | 1 |
Lopez-Lopez, I | 1 |
Rodelo-Haad, C | 1 |
Agüera, ML | 1 |
Cabello-Jabalquinto, R | 1 |
Esquivias-Motta, E | 1 |
Navarro, MD | 1 |
Aljama, P | 1 |
Rodriguez-Benot, A | 1 |
Kaneko, K | 1 |
Kawai, T | 1 |
Watanabe, N | 1 |
Wada, Y | 1 |
Onodera, M | 1 |
Murashima, A | 1 |
Mozaffari, S | 1 |
Abdolghaffari, AH | 1 |
Nikfar, S | 1 |
Abdollahi, M | 1 |
Angelberger, S | 1 |
Reinisch, W | 1 |
Messerschmidt, A | 1 |
Miehsler, W | 1 |
Novacek, G | 1 |
Vogelsang, H | 1 |
Dejaco, C | 1 |
Marder, W | 1 |
Ganser, MA | 1 |
Romero, V | 1 |
Hyzy, MA | 1 |
Gordon, C | 1 |
McCune, WJ | 1 |
Somers, EC | 1 |
Langagergaard, V | 1 |
Pedersen, L | 1 |
Gislum, M | 1 |
Nørgard, B | 1 |
Sørensen, HT | 1 |
Motta, M | 1 |
Ciardelli, L | 1 |
Marconi, M | 1 |
Gasparoni, A | 1 |
Lojacono, A | 1 |
Chirico, G | 1 |
Mironova, VA | 1 |
Audra, P | 1 |
Alter, BP | 1 |
Kanis, SL | 1 |
Modderman, S | 1 |
Escher, JC | 1 |
Erler, N | 1 |
Beukers, R | 1 |
de Boer, N | 1 |
Bodelier, A | 1 |
Depla, ACTM | 1 |
Dijkstra, G | 1 |
van Dijk, ARM | 1 |
Gilissen, L | 1 |
Hoentjen, F | 1 |
Jansen, JM | 1 |
Kuyvenhoven, J | 1 |
Mahmmod, N | 1 |
Mallant-Hent, RC | 1 |
van der Meulen-de Jong, AE | 1 |
Noruzi, A | 1 |
Oldenburg, B | 1 |
Oostenbrug, LE | 1 |
Ter Borg, PCJ | 1 |
Pierik, M | 1 |
Romberg-Camps, M | 1 |
Thijs, W | 1 |
West, R | 1 |
de Lima, A | 1 |
van der Woude, CJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease[NCT00904878] | 1,500 participants (Anticipated) | Observational | 2007-08-31 | Recruiting | |||
Pregnancy in Greek Female Patients With Inflammatory Bowel Disease - Panhellenic Recording[NCT05562726] | 100 participants (Anticipated) | Observational [Patient Registry] | 2020-01-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for azathioprine and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Topics: Autoimmune Diseases; Azathioprine; Child; Female; Humans; Immunosuppressive Agents; Pregnancy; Pregn | 2020 |
Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
Topics: Adult; Azathioprine; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Pregnancy; Pregnancy C | 2015 |
[Pregnancy in women who underwent organ transplantation].
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Organ Transplantation; Preg | 1994 |
11 other studies available for azathioprine and Delayed Effects, Prenatal Exposure
Article | Year |
---|---|
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disea | 2021 |
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disea | 2021 |
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disea | 2021 |
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disea | 2021 |
A Severe Neonatal Lymphopenia Associated With Administration of Azathioprine to the Mother in a Context of Crohn's Disease.
Topics: Azathioprine; Crohn Disease; Female; Homozygote; Humans; Immunosuppressive Agents; Infant, Newborn; | 2018 |
Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Fertilization; Graft Rejection; Humans; Immu | 2018 |
Spontaneous recovery from suppressed B cell production and proliferation caused by intrauterine azathioprine exposure in the fetal period.
Topics: Adult; Azathioprine; B-Lymphocytes; Cell Proliferation; Female; Humans; Immunosuppressive Agents; In | 2019 |
Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.
Topics: Adult; Azathioprine; Breast Feeding; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Fe | 2011 |
In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cohort Studies; Developmental Disabilities | 2013 |
Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Topics: Abnormalities, Drug-Induced; Azathioprine; Cohort Studies; Denmark; Female; Humans; Immunosuppressiv | 2007 |
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents.
Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Female; Humans; Hydroxychloroquine; Immune System; | 2007 |
[Electron microscope analysis of the transplacental effect of azathioprine on the pancreas of albino mouse embryos].
Topics: Animals; Azathioprine; Embryo, Mammalian; Female; Islets of Langerhans; Mice; Microscopy, Electron; | 1983 |
Neonatal pancytopenia after maternal azathioprine therapy.
Topics: Azathioprine; Female; Humans; Infant, Newborn; Pancytopenia; Pregnancy; Prenatal Exposure Delayed Ef | 1985 |
Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life.
Topics: Adalimumab; Adult; Anti-Bacterial Agents; Autoimmune Diseases; Cesarean Section; Child Development; | 2021 |